Tag Archives: Dei

Dr. Mathias Magoola – New mRNA innovation targets major outbreak-causing ebolaviruses, including Zaire, Sudan, Bundibugyo and the West African/Makona lineage KAMPALA, Uganda — Dei BioPharma has announced the submission of a utility patent application to the United States Patent and Trademark Office for a next-generation mRNA vaccine platform designed to provide broad protection against the world’s most dangerous Ebola-causing viruses. × …

By Mulengera Reporters The Government of Uganda officially invested up to Shs750bn into the Matugga-based DEI Pharmaceuticals manufacturer, which earned Ugandans a shareholding of 9% in the business. This PPP decision was controversial from the very inception as a significant number of MPs protested and questioned the prudence of doing such a thing.   Andrew Mwenda, a renowned Museveni supporter, …

At the Dei BioPharma campus in Matugga, rows of laboratories and production units are being built with one goal, to shift Uganda from importing medicines to manufacturing them. It’s a bold gamble in a global industry dominated by a handful of powerful countries, and one that carries implications far beyond health. For government officials who toured the facility ahead of …

Kampala/Matugga – Troubling signs are emerging from Uganda’s flagship pharmaceutical and biotechnology giant, Dei Biopharma, as reports confirm a massive exodus of top scientists and senior managers from the company’s state-of-the-art vaccine and drug manufacturing complex in Kigogwa–Matugga. The Dei Biopharma manufacturing facility in Matugga, near Kampala, Once hailed as a landmark investment that would anchor Africa’s healthcare self-sufficiency, the …